Steroid Refractory Acute Graft Versus Host Disease

Also known as: Steroid-refractory Acute Graft-versus-Host Disease / Steroid-Refractory Acute Graft Versus Host Disease

Drug	Drug Name	Drug Description
DB00087	Alemtuzumab	A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis.

Drug	Drug Name	Target	Type
DB00087	Alemtuzumab	CAMPATH-1 antigen	target
DB00087	Alemtuzumab	Low affinity immunoglobulin gamma Fc region receptor III-B	target
DB00087	Alemtuzumab	Low affinity immunoglobulin gamma Fc region receptor III-A	target
DB00087	Alemtuzumab	High affinity immunoglobulin gamma Fc receptor I	target
DB00087	Alemtuzumab	Low affinity immunoglobulin gamma Fc region receptor II-a	target
DB00087	Alemtuzumab	Low affinity immunoglobulin gamma Fc region receptor II-b	target
DB00087	Alemtuzumab	Low affinity immunoglobulin gamma Fc region receptor II-c	target

Drug	Drug Name	Phase	Status	Count
DB16698	Neihulizumab	1	Completed	1
DB00553	Methoxsalen	3	Terminated	1
DB08877	Ruxolitinib	3	Terminated	1
DB18357	T-Guard	3	Terminated	2
DB00058	Alpha-1-proteinase inhibitor	Not Available	No Longer Available	1
DB11105	Benzalkonium	Not Available	No Longer Available	1